Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
14 studies found for:    Open Studies | Exclude Unknown | pancreatic disease | NIDDK
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | Exclude Unknown | pancreatic disease | NIDDK
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Condition: Cystic Fibrosis
Intervention:
2 Recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
3 Recruiting Diagnosing and Treating Low Blood Sugar Levels
Conditions: Hypoglycemia;   Insulinoma
Intervention:
4 Recruiting YF476 in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome
Condition: Carcinoid
Intervention: Drug: YF476
5 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
6 Recruiting Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease
Conditions: Cystic Fibrosis;   Liver Disease
Intervention:
7 Recruiting Genetic Modifiers of Cystic Fibrosis Related Diabetes
Condition: Cystic Fibrosis Related Diabetes
Intervention:
8 Recruiting Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
9 Not yet recruiting BioEnergetics and Metabolomics in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
10 Recruiting Type 1 Diabetes Recurrence in Pancreas Transplants
Condition: Diabetes Mellitus, Type 1
Intervention:
11 Recruiting Studies of Organ Transplantation in Animals and Man
Condition: Diabetes Mellitus
Intervention:
12 Recruiting Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures
Condition: Indeterminate Bile Duct Stricture
Interventions: Procedure: Multiple brushings;   Procedure: Multimodality tissue sampling
13 Recruiting Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Hypoglycemia Reduction in Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Device: Diabetes Assistant (DiAs) (Unified Safety System (USS) Virginia);   Device: Sensor-Augmented Pump Therapy (placebo)
14 Not yet recruiting Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Oversight Control in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1 (T1DM)
Intervention: Device: Diabetes Assistant (DiAs)

Indicates status has not been verified in more than two years